Sera Prognostics (SERA) Free Cash Flow (2020 - 2026)
Sera Prognostics (SERA) posted Free Cash Flow of -$8.8 million for Q1 2026, down 36.16% on a QoQ basis from -$6.4 million in Q4 2025, and down 16.23% year-over-year from -$10.5 million in Q1 2025.
Sera Prognostics (SERA) Free Cash Flow (2020 - 2026) Analysis & Trends
Sera Prognostics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$8.8 million for Q1 2026.
- Quarterly Free Cash Flow fell 16.23% year-over-year to -$8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.6 million (down 2.97% YoY) and the FY2025 annual result came in at -$26.3 million, down 84.97% from the prior year.
- Free Cash Flow was -$8.8 million for Q1 2026 at Sera Prognostics, down from -$6.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.0 million in Q1 2024 and bottomed at -$9.6 million in Q1 2022.
- A 5-year average of -$6.6 million and a median of -$7.0 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow soared 201.2% — and 2025, when it sank 251.76%.
- Sera Prognostics' Free Cash Flow stood at -$7.4 million in 2022, then increased by 8.75% to -$6.8 million in 2023, then advanced by 7.57% to -$6.3 million in 2024, then fell by 2.9% to -$6.4 million in 2025, then sank by 36.16% to -$8.8 million in 2026.
- Business Quant data shows SERA's Free Cash Flow at -$8.8 million in Q1 2026, -$6.4 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | -8.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.78 Mn |
| Mar 31, 2026 | -8.78 Mn |
| Dec 31, 2025 | -6.45 Mn |
| Dec 31, 2025 | -6.45 Mn |
| Sep 30, 2025 | -6.59 Mn |
| Sep 30, 2025 | -6.59 Mn |
| Jun 30, 2025 | -5.75 Mn |
| Jun 30, 2025 | -5.75 Mn |
| Mar 31, 2025 | -7.56 Mn |
| Mar 31, 2025 | -7.56 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Jun 30, 2024 | -5.94 Mn |
| Jun 30, 2024 | -5.94 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Dec 31, 2023 | -6.78 Mn |
| Dec 31, 2023 | -6.78 Mn |